These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4913377)

  • 21. Experimental aspergillosis in mice. 1. Pathogenic potential of Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger.
    Bhatia VN; Mohapatra LN
    Mykosen; 1969 Nov; 12(11):651-4. PubMed ID: 5398020
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathogenicity of Aspergillus and Candida (author's transl)].
    de Haller R
    Prax Klin Pneumol; 1977 May; 31(5):539-45. PubMed ID: 887612
    [No Abstract]   [Full Text] [Related]  

  • 23. Response of turkey poults to aerosolized spores of Aspergillus fumigatus and aflatoxigenic and nonaflatoxigenic strains of Aspergillus flavus.
    Richard JL; Cutlip RC; Thurston JR; Songer J
    Avian Dis; 1981; 25(1):53-67. PubMed ID: 6791628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nodular lesion within lung cavity.
    N Y State J Med; 1973 Mar; 73(6):768-76. PubMed ID: 4510961
    [No Abstract]   [Full Text] [Related]  

  • 25. Precipitins in serums from sheep infected with Aspergillus fumigatus.
    Thurston JR; Cysewski SJ; Pier AC; Richard JL
    Am J Vet Res; 1972 May; 33(5):929-33. PubMed ID: 4623391
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tools, progress and questions in the molecular study of Aspergillus fumigatus and invasive aspergillosis].
    Latgé JP; Paris S; Sarfati J; Debeaupuis JP; Diaquin M; Girardin H
    Pathol Biol (Paris); 1994 Sep; 42(7):632-9. PubMed ID: 7877854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EXPERIMENTAL PULMONARY ASPERGILLOSIS.
    SIDRANSKY H; VERNEY E; BEEDE H
    Arch Pathol; 1965 Mar; 79():299-309. PubMed ID: 14246209
    [No Abstract]   [Full Text] [Related]  

  • 28. Allergic bronchopulmonary aspergillosis: characterization of antibodies and results of treatment.
    Slavin RG; Million L; Cherry J
    J Allergy; 1970 Sep; 46(3):150-5. PubMed ID: 4990018
    [No Abstract]   [Full Text] [Related]  

  • 29. Invasive pulmonary aspergillosis: high incidence of disseminated intravascular coagulation in fatal cases.
    Lai CC; Liaw SJ; Lee LN; Hsiao CH; Yu CJ; Hsueh PR
    J Microbiol Immunol Infect; 2007 Apr; 40(2):141-7. PubMed ID: 17446962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Concept and diagnostic importance of the "fungal drusen"].
    Gemeinhardt H
    Pathol Microbiol (Basel); 1969; 33(2):77-94. PubMed ID: 5371832
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental aspergillosis in the guinea pig. Dynamic study of the role of alveolar macrophages in the defense of the respiratory tract, after massive inhalation of Aspergillus fumigatus spores].
    Gernez-Rieux C; Voisin C; Aerts C; Wattel F; Gosselin B
    Rev Tuberc Pneumol (Paris); 1967; 31(6):705-25. PubMed ID: 4914810
    [No Abstract]   [Full Text] [Related]  

  • 32. Aspergillus infection of the airways: computed tomography and pathologic findings.
    Franquet T; Müller NL; Oikonomou A; Flint JD
    J Comput Assist Tomogr; 2004; 28(1):10-6. PubMed ID: 14716226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease.
    Chang YC; Segal BH; Holland SM; Miller GF; Kwon-Chung KJ
    J Clin Invest; 1998 May; 101(9):1843-50. PubMed ID: 9576747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulomatous and mycotoxic syndromes in mice due to Aspergillus clavatus Desm.
    Blyth W; Lloyd MM
    Sabouraudia; 1971 Nov; 9(3):263-72. PubMed ID: 5135089
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccinate against aspergillosis! A call to arms of the immune system.
    Stevens DA
    Clin Infect Dis; 2004 Apr; 38(8):1131-6. PubMed ID: 15095219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental visceral aspergillosis.
    Sidransky H; Epstein SM; Verney E; Horowitz C
    Am J Pathol; 1972 Oct; 69(1):55-70. PubMed ID: 4628112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental study of the pathogenicity of aspergilli for mice.
    Ford S; Friedman L
    J Bacteriol; 1967 Oct; 94(4):928-33. PubMed ID: 6051365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients.
    Danner BC; Didilis V; Dörge H; Mikroulis D; Bougioukas G; Schöndube FA
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):771-6. PubMed ID: 18573846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pathology of Aspergillus flavus infection in uncompromised host.
    Gumaa SA; el Hassan AM
    East Afr Med J; 1984 Nov; 61(11):837-42. PubMed ID: 6442979
    [No Abstract]   [Full Text] [Related]  

  • 40. [Estimation of infection by Aspergillus fumigatus in mice infected experimentally by the respiratory route].
    Jáuregui A; Martínez Palacios ML; Arnaiz I; Pontón J; Cisterna R
    Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):126-30. PubMed ID: 8499510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.